Erick H Turner

Summary

Country: USA

Publications

  1. ncbi Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder
    Erick H Turner
    Section on Biological Rhythms, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA
    J Clin Psychopharmacol 22:216-20. 2002
  2. ncbi Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
    Erick H Turner
    Mood Disorders Center, Portland VA Medical Center, Portland, OR 97239, USA
    Pharmacol Ther 109:325-38. 2006
  3. ncbi 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin
    Erick H Turner
    Mental Health Division, Mood Disorders Research Center, Portland VA Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    Med Hypotheses 65:138-44. 2005
  4. ncbi Patients with seasonal affective disorder have lower odor detection thresholds than control subjects
    Teodor T Postolache
    Section on Biological Rhythms, National Institute of Mental Health NIH, 10 Center Dr, Room 3S 231, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 59:1119-22. 2002
  5. ncbi Selective publication of antidepressant trials and its influence on apparent efficacy
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    N Engl J Med 358:252-60. 2008
  6. ncbi Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center
    Steven K Dobscha
    Portland Veterans Affairs Medical Center, Oregon 97207, USA
    Psychiatr Serv 54:195-200. 2003
  7. ncbi Is it always unethical to use a placebo in a clinical trial?
    Andreas Stang
    Institute of Medical Epidemiology, Biometry, and Informatics at the Medical Faculty of the Martin Luther University of Halle Wittenberg, Germany
    PLoS Med 2:e72. 2005
  8. ncbi Efficacy of antidepressants
    Erick H Turner
    BMJ 336:516-7. 2008

Detail Information

Publications8

  1. ncbi Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder
    Erick H Turner
    Section on Biological Rhythms, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA
    J Clin Psychopharmacol 22:216-20. 2002
    ..These data suggest that single doses of metergoline may have antidepressant effects that last several days. Possible mechanisms include 5-hydroxytryptamine(2) receptor downregulation and dopamine agonism...
  2. ncbi Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
    Erick H Turner
    Mood Disorders Center, Portland VA Medical Center, Portland, OR 97239, USA
    Pharmacol Ther 109:325-38. 2006
    ..Safety issues with 5-HTP are also reviewed, with emphasis on eosinophilia myalgia syndrome (EMS) and serotonin syndrome...
  3. ncbi 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin
    Erick H Turner
    Mental Health Division, Mood Disorders Research Center, Portland VA Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    Med Hypotheses 65:138-44. 2005
    ..Several double-blind studies have shown 5-HTP to be effective in the treatment of nondrug-induced depression. We hypothesize that patients who become depressed on IFN will respond to the synergistic combination of SSRIs plus 5-HTP...
  4. ncbi Patients with seasonal affective disorder have lower odor detection thresholds than control subjects
    Teodor T Postolache
    Section on Biological Rhythms, National Institute of Mental Health NIH, 10 Center Dr, Room 3S 231, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 59:1119-22. 2002
    ..Because the olfactory system has a modulatory role in seasonal photoperiodic responses in certain species, we hypothesized that olfactory function may differ between patients with seasonal affective disorder and healthy control subjects...
  5. ncbi Selective publication of antidepressant trials and its influence on apparent efficacy
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    N Engl J Med 358:252-60. 2008
    ..Selective publication of clinical trials--and the outcomes within those trials--can lead to unrealistic estimates of drug effectiveness and alter the apparent risk-benefit ratio...
  6. ncbi Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center
    Steven K Dobscha
    Portland Veterans Affairs Medical Center, Oregon 97207, USA
    Psychiatr Serv 54:195-200. 2003
    ..The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center...
  7. ncbi Is it always unethical to use a placebo in a clinical trial?
    Andreas Stang
    Institute of Medical Epidemiology, Biometry, and Informatics at the Medical Faculty of the Martin Luther University of Halle Wittenberg, Germany
    PLoS Med 2:e72. 2005
    ..Critics of such trials argue that if a proven effective therapy exists, a placebo should not be used. But proponents argue that placebo trials are still crucial to prove the efficacy and safety of many treatments...
  8. ncbi Efficacy of antidepressants
    Erick H Turner
    BMJ 336:516-7. 2008